Auxico Resources Canada Inc

Company Profile

molecular partners is a thriving and steadily growing clinical-stage biopharmaceutical company working to advance modern medicine and significantly improve the management of serious diseases. we are developing a powerful new class of potent, specific and versatile small protein therapies called darpins. the development of a broad portfolio of therapeutic product candidates in oncology and ophthalmology allowed a successful listing of the company on the six swiss exchange (moln).